(HealthDay)—For physically active adults with type 1 diabetes, the addition of glucagon delivery to a closed-loop system using wearable sensors with automated exercise detection is associated with reduced hypoglycemia, ...
May 16, 2018
0
2
(HealthDay)—For young adults with type 1 diabetes, there are differences in arrhythmic risk and cardiac repolarization during nocturnal versus daytime hypoglycemia, according to a study published online Feb. 17 in Diabetes ...
Feb 28, 2017
0
0
(HealthDay)—Dasiglucagon is well tolerated and is associated with an early pharmacodynamic response similar to that of GlucaGen for severe hypoglycemia, according to a study published online Dec. 22 in Diabetes Care.
Jan 3, 2018
0
2
One size chart doesn't fit all when it comes to evaluating birth weight and health outcomes of newborns.
Jul 31, 2013
0
0
(HealthDay)—Youth with type 1 diabetes mellitus (T1DM) exhibit a pattern of regional diffusion tensor imaging differences that is suggestive of axonal injury or degeneration and may be related to episodes of severe hypoglycemia, ...
Nov 15, 2012
0
0
A study matching newborn glucose concentration screening results with fourth-grade achievement test scores suggests that early transient newborn hypoglycemia (low blood sugar) was associated with lower test scores at age ...
Aug 24, 2015
0
12
New research from the Endocrine Society and Avalere Health finds that clinicians lack the resources to identify, assess and manage patients who are at a high risk of developing hypoglycemia, or episodes of dangerously low ...
Mar 5, 2018
0
5
A mysterious and sometimes fatal brain disease that has afflicted children in northeastern India for years could be linked to a toxic substance in litchi fruits, US researchers said Thursday.
Jan 29, 2015
0
12
(HealthDay)—For adolescents with type 1 diabetes (T1D), a closed-loop control (CLC) system is associated with improved glycemic control and reduced exposure to hypoglycemia during prolonged exercise, cold temperatures, ...
Sep 18, 2017
0
0
(HealthDay)—Basal insulin analogues for type 2 diabetes mellitus (T2DM) do not substantially differ in their glucose-lowering effect, according to a review published online July 10 in the Annals of Internal Medicine.
Jul 18, 2018
0
0
